RWC UNPLUGGED │ 8:00 am – 12:00 pm

RWC Unplugged is couched as the first and only physician-driven format. The program will provide data-based, unfiltered and “raw” discussions and debates about drugs and devices that may impact retina. This session will be led by Drs. Pravin Dugel, Barry Kuppermann and Peter Kaiser; they will be joined by world-renowned retina physicians, industry leaders and investors. Don's miss this interesting and engaging education session scheduled one day prior to RWC main sessions and at the same hotel. There is no additional fee for RWC registrants to attend.


Official Start of the Meeting

LUNCH PROGRAM │ 12:00 pm – 1:00 pm

Don't miss this opportunity to engage faculty and colleagues in a smaller group setting. Speakers will deliver didactic presentations on a hot topic and then take questions from the audience. Lunch will be provided.

GENERAL SESSIONS │ 1:00 pm – 5:45pm

Welcome Message

Macular Surgery

  • Pneumatic vs. Chemical Approaches to Vitreomacular Traction
  • Ectopic Inner Foveal Layers in ERMs Surgical Results
  • Submacular Irrigation for Large Macular Holes
  • Development of a Deep Learning System for Digitally Enhanced Internal Limiting Membrane Peeling
  • Approach to Lamellar Macular Hole Repair
  • Inverted ILM Flap Techniques and Indications
  • Platelet-rich Plasma for Myopic Macular Holes
  • Autologous Tissue Transplantation for Macular Holes
  • Submacular Hemorrhage Displacement
  • Optic Pits
  • Managing Myopic Foveoschisis: Surgery or Observation
  • Abstract Presentations
  • Panel Discussion

Medical Retina: Retinal Vein Occlusion

  • Effect of Anti-VEGF and Steroids Treatment on Retinal Non-perfusion
  • Multimodal Retinal Imaging for Alzheimer's Disease
  • SCORE-2 Results and Implications to Clinical Practice
  • LUMINOUS Study Results
  • Comparative Studies of Treatments for RVO: LEAVO Study Results
  • Addressing RVO with Corticosteroids
  • How to Use Combination Therapy for RVO Effectively
  • Abstract Presentations
  • Panel Discussion

Ocular Oncology

  • Management of High-risk Choroidal Melanoma
  • Invisible Tumors or Giant Iris Melanocyte
  • Using Imaging to Help Diagnose Ocular Tumors
  • Future Therapeutics for Ocular Oncology
  • Anti-VEGF Therapy for Radiation Retinopathy
  • Choroidal Nevus Risk Factors: Weighted Relevance Based on Molecular Prognostication
  • The Expanding Use of Ophthalmic Artery Chemosurgery
  • PANEL: Surgical and Medical Management of Ocular Oncology Cases

WELCOME RECEPTION │ 6:00 pm – 7:30 pm

Take this opportunity to network one-on-one with faculty and colleagues while light appetizers and drinks are served.